MicroMembrane Medical completes nearly 100 million RMB in Series A financing

▤ Summary

MicroMembrane Medical has completed nearly 100 million RMB in Series A financing. The company develops ophthalmic surgical robots and has also completed registration for clinical trials of a multi-center randomization system in China. The round was led by Qianhang Capital, with continued investment from Minggui Capital and participation from several other well-known institutions. The financing should help the company accelerate product development, clinical validation, and commercialization in eye-surgery automation.

$ Funding

▦ Linked Companies